Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Cytosurge logo — FluidFM® for single-cell manipulation and CRISPR, turning ge...

Cytosurge

FluidFM® for single-cell manipulation and CRISPR, turning genetic designs into cures, bridging design with manufacturing

Founded 2009 Switzerland Switzerland 42 employees Information Technology

General Information

Company Name Cytosurge
Founded Year 2009
Location Switzerland Switzerland +1
Employees 42
Industries Information Technology
Social

Get notified when Cytosurge moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cytosurge

Cytosurge is a pioneering venture that leverages its proprietary FluidFM technology to drive advancements in cellular research. Focused on single-cell manipulation, the company aims to deepen the understanding of critical cellular processes, notably those underlying cancer. With the FluidFM OMNIUM platform, Cytosurge has enabled the extraction of single-cell biopsies from living cells, facilitating live-sequencing and temporal transcriptomics analysis. Moreover, the company's CellEDIT Service offers genetically engineered cell lines through intra-nuclear injections of CRISPR RNPs, emphasizing precision gene engineering. Founded in 2009, Cytosurge aspires to unlock novel cures and enable longer, healthier lives by translating next-generation genetic designs into living cells. The company is committed to bridging the gap between genetic design tools and manufacturing, paving the way for innovative therapies. With a focus on genomics, CRISPR gene editing, and cell line development, Cytosurge is at the forefront of genetic engineering advancements. While specific investment details are not available at this time, the company's innovative approach and strategic vision position it as an intriguing prospect for potential investment opportunities.

Taxonomy: Single Cell Manipulation, CRISPR Gene Editing, Genetic Engineering, Nanotechnology Solutions, Cell Line Development, FluidFM Technology, Live Cell Sequencing, Transcriptomics Analysis, Genetically Engineered Cell Lines, AFM Solutions, Virology Research, Mechanobiology, Bioprocessing, Biomedical Research Tools, Bioprinting

No funding data available for Cytosurge yet.

Get notified when Cytosurge raises funding

Cytosurge Alternatives & Competitors

Cytosurge vs
ExpressCells
ExpressCells United States

Using genetic engineering to create knock-in cell lines for biological research

Series Unknown
2-10 employees
Biotechnology
Cytosurge vs
Deep Biotech Solutions
Deep Biotech Solutions Hungary

Ready-to-use results from Next-Generation Sequencing to CRISPR/Cas9, tailored to your needs.

Pre Seed
2 employees
Biotechnology, Health Care
Cytosurge vs
Tmunity Therapeutics
Tmunity Therapeutics

Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse arr...

Acquired
12 employees
Biotechnology, Health Care

FAQ About Cytosurge

FluidFM® for single-cell manipulation and CRISPR, turning genetic designs into cures, bridging design with manufacturing
Cytosurge was founded in 2009.
Cytosurge is headquartered in Switzerland.
Cytosurge operates in the following industries: Information Technology.
Cytosurge has approximately 42 employees.
Top alternatives and competitors to Cytosurge include ExpressCells, Deep Biotech Solutions, Tmunity Therapeutics, Samplix, Marker Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cytosurge and ExpressCells are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cytosurge and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy